Susquehanna Fundamental Investments, LLC Ab Cellera Biologics Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $1.33 Million - $2.04 Million	-140,251 Reduced 40.78%	203,675 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $193,843 - $288,237	21,070 Added 6.53%	343,926 $3.4 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $1.31 Million - $2.49 Million	175,919 Added 119.72%	322,856 $3.15 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $1.91 Million - $2.61 Million	146,937 New	146,937 $2.1 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.